---
title: "2C-E - Complete Profile"
substance: "2C-E"
chemical_name: "2-(2,5-dimethoxy-4-ethylphenyl)ethanamine"
category: "Psychedelic"
legal_status: "Schedule I (US) - Controlled Substance"
description: "An intense and challenging phenethylamine psychedelic known for its demanding bodyload and profound psychological effects - one of Shulgin's most powerful creations"
permalink: "/dyos-domain/substances/2c-e/"
---

<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚Üí <a href="/dyos-domain/psychedelics/">Psychedelics</a> ‚Üí <span>2C-E</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>‚ö° 2C-E</h1>
        <h2 class="chemical-name">2-(2,5-dimethoxy-4-ethylphenyl)ethanamine</h2>
        
        <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="2C-E" 
                data-category="Psychedelics" 
                data-chemical="2-(2,5-dimethoxy-4-ethylphenyl)ethanamine">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <span class="alt-name">2C-E</span>
            <span class="alt-name">2CE</span>
            <span class="alt-name">Europa</span>
            <span class="alt-name">Eternity</span>
            <span class="alt-name">Aquarust</span>
            <span class="alt-name">Hummingbird</span>
            <span class="alt-name">The Eagle</span>
            <span class="alt-name">2,5-dimethoxy-4-ethylphenethylamine</span>
            <span class="alt-name">DMPEA-E</span>
            <span class="alt-name">E-tabs</span>
            <span class="alt-name">Electric</span>
            <span class="alt-name">Synthesis</span>
            <span class="alt-name">Four-Ethyl</span>
            <span class="alt-name">2C-Ethyl</span>
            <span class="alt-name">Phenethylamine-E</span>
            <span class="alt-name">Shulgin's Challenge</span>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category psychedelic">Psychedelic</span>
          <span class="legal-status schedule-1">Schedule I</span>
          <span class="duration very-long">8-12 hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/assets/substances/2c-e.jpg" alt="2C-E powder and tablets" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>2C-E Phenethylamine Structure</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pure 2C-E (HCl salt)</h4>
          <ul>
            <li><strong>Appearance:</strong> White to off-white crystalline powder</li>
            <li><strong>Texture:</strong> Fine crystalline powder, sometimes clumpy</li>
            <li><strong>Color:</strong> Pure white when fresh, may discolor with age</li>
            <li><strong>Taste:</strong> Extremely bitter and numbing</li>
            <li><strong>Solubility:</strong> Soluble in water and alcohol</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Common Street Forms</h4>
          <ul>
            <li><strong>Powder:</strong> Most common form requiring precise scales</li>
            <li><strong>Capsules:</strong> Pre-measured doses in gel caps</li>
            <li><strong>Tablets:</strong> Pressed pills, sometimes with logos</li>
            <li><strong>Liquid solutions:</strong> Dissolved in alcohol or water</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†Ô∏è Misidentification Risks</h4>
          <p><strong>NBOMe series:</strong> Extremely dangerous substitutes with lethal doses</p>
          <p><strong>Other 2C compounds:</strong> May be sold as 2C-E with different potencies</p>
          <p><strong>DOx compounds:</strong> Much longer duration and higher toxicity</p>
          <p><strong>Unknown research chemicals:</strong> Untested compounds with unknown effects</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Threshold</span>
          <span class="dose-amount">5-10mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light</span>
          <span class="dose-amount">10-15mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Common</span>
          <span class="dose-amount">15-25mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">Strong</span>
          <span class="dose-amount">25-35mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Heavy/Dangerous</span>
          <span class="dose-amount">35mg+</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Critical Dosage Information</h4>
        <ul>
          <li><strong>Onset:</strong> 30-90 minutes (slow, leads to redosing accidents)</li>
          <li><strong>Duration:</strong> 8-12 hours total experience</li>
          <li><strong>Peak:</strong> 3-5 hours after onset</li>
          <li><strong>Comedown:</strong> 4-6 hours gradual decline</li>
          <li><strong>Body load:</strong> Intense throughout entire experience</li>
          <li><strong>Tolerance:</strong> Cross-tolerance with other phenethylamines</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>CRITICAL WARNING:</strong> 2C-E has a steep dose-response curve - small increases in dose cause dramatic increases in intensity and body load. Never exceed 25mg without extensive experience.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline</h4>
        <div class="timeline-item">
          <span class="time">T+0:30-1:30</span>
          <span class="effect">Onset - body load, nausea, initial visual changes</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+1:30-5:00</span>
          <span class="effect">Peak - intense visuals, heavy body load, altered consciousness</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+5:00-8:00</span>
          <span class="effect">Plateau - sustained effects, continued intensity</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+8:00-12:00</span>
          <span class="effect">Comedown - gradual decline, residual stimulation</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÖ Positive Effects</h4>
          <ul>
            <li>Intense, colorful visual hallucinations and geometric patterns</li>
            <li>Deep introspective and philosophical insights</li>
            <li>Enhanced emotional depth and empathy</li>
            <li>Profound alterations in consciousness</li>
            <li>Enhanced appreciation for music and art</li>
            <li>Spiritual and mystical experiences</li>
            <li>Enhanced pattern recognition and creativity</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùå Negative Effects</h4>
          <ul>
            <li>Severe, persistent body load and physical discomfort</li>
            <li>Intense nausea and gastrointestinal distress</li>
            <li>Muscle tension and jaw clenching</li>
            <li>Temperature dysregulation and chills</li>
            <li>Anxiety, paranoia, and thought loops</li>
            <li>Vasoconstriction and circulation problems</li>
            <li>Overwhelming intensity at higher doses</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>2C-E is a potent partial agonist at serotonin 5-HT2A receptors, with high binding affinity and selectivity. The ethyl substitution at the 4-position increases potency and significantly enhances the intensity of somatic effects compared to other 2C compounds. It also shows activity at 5-HT2C receptors and moderate affinity for 5-HT1A receptors.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor">5-HT2A Receptor</span>
            <span class="activity">Partial Agonist (Very High Affinity)</span>
            <span class="effect">Visual hallucinations, altered consciousness</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">5-HT2C Receptor</span>
            <span class="activity">Partial Agonist</span>
            <span class="effect">Mood effects, appetite suppression</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">5-HT1A Receptor</span>
            <span class="activity">Moderate Affinity</span>
            <span class="effect">Body sensations, anxiety modulation</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">Œ±1-Adrenergic</span>
            <span class="activity">Antagonist</span>
            <span class="effect">Vasoconstriction, body load</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">Dopamine D1</span>
            <span class="activity">Weak Affinity</span>
            <span class="effect">Minor stimulant-like effects</span>
          </div>
        </div>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Absorption:</strong> Rapid oral absorption, effects begin 30-90 minutes</p>
          <p><strong>Metabolism:</strong> Hepatic metabolism, likely via MAO-A and CYP enzymes</p>
          <p><strong>Half-life:</strong> Estimated 6-10 hours</p>
          <p><strong>Duration:</strong> 8-12 hours total effects</p>
          <p><strong>Bioavailability:</strong> High oral bioavailability</p>
          <p><strong>Excretion:</strong> Renal elimination of metabolites</p>
        </div>

        <h4>Structural Activity Relationships</h4>
        <div class="neurotoxicity-info">
          <p><strong>Ethyl Substitution:</strong> The 4-ethyl group increases potency and body load intensity</p>
          <p><strong>Methoxy Groups:</strong> 2,5-dimethoxy substitution pattern essential for activity</p>
          <p><strong>Phenethylamine Backbone:</strong> Core structure responsible for 5-HT2A selectivity</p>
          <p><strong>Body Load Profile:</strong> Ethyl group particularly associated with somatic effects</p>
        </div>

        <h4>Unique Pharmacological Properties</h4>
        <ul>
          <li><strong>High Body Load:</strong> More intense somatic effects than other 2C compounds</li>
          <li><strong>Steep Dose-Response:</strong> Small dose increases cause dramatic effect increases</li>
          <li><strong>Visual Intensity:</strong> Particularly strong visual effects with less confusion</li>
          <li><strong>Emotional Intensity:</strong> Deep emotional and introspective effects</li>
          <li><strong>Temperature Sensitivity:</strong> Notable effects on thermoregulation</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†Ô∏è Safety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® Critical Warnings</h4>
          <ul>
            <li><strong>Intense Body Load:</strong> Severe physical discomfort throughout experience</li>
            <li><strong>Steep Dose Curve:</strong> Small increases cause dangerous intensity jumps</li>
            <li><strong>Long Duration:</strong> 8-12 hours of intense effects</li>
            <li><strong>NBOMe Risk:</strong> Often sold as safer substitutes with lethal doses</li>
            <li><strong>Vasoconstriction:</strong> Circulation problems and potential complications</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°Ô∏è Safety Precautions</h4>
          <ul>
            <li><strong>Precise Dosing:</strong> Use analytical scale accurate to 0.1mg</li>
            <li><strong>Test Substances:</strong> Use multiple reagent tests to verify identity</li>
            <li><strong>Set and Setting:</strong> Comfortable environment for 12+ hours</li>
            <li><strong>Trip Sitter:</strong> Experienced sober person present</li>
            <li><strong>No Redosing:</strong> Never redose due to slow onset</li>
            <li><strong>Comfort Measures:</strong> Blankets, music, safe space for body load</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Medical Contraindications</h4>
        <p><strong>Do not use if you have:</strong> Cardiovascular disease, hypertension, seizure disorders, psychiatric conditions, are taking psychiatric medications, or have family history of psychosis or heart problems.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏è Drug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ Dangerous</h4>
          <ul>
            <li><strong>MAOIs:</strong> Potentially fatal serotonin syndrome</li>
            <li><strong>SSRIs/SNRIs:</strong> Reduced effects, possible serotonin syndrome</li>
            <li><strong>Stimulants:</strong> Dangerous cardiovascular stress and overheating</li>
            <li><strong>NBOMe Series:</strong> Extreme risk of seizures and death</li>
            <li><strong>DXM:</strong> Serotonin syndrome and increased body load</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° Risky</h4>
          <ul>
            <li><strong>Cannabis:</strong> May dramatically increase anxiety and body load</li>
            <li><strong>Alcohol:</strong> Impaired judgment and increased accident risk</li>
            <li><strong>Other Psychedelics:</strong> Unpredictable interactions and increased intensity</li>
            <li><strong>Tramadol:</strong> Serotonin syndrome risk</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† Use Caution</h4>
          <ul>
            <li><strong>Caffeine:</strong> May increase anxiety and vasoconstriction</li>
            <li><strong>Nicotine:</strong> Enhanced vasoconstriction effects</li>
            <li><strong>Blood Pressure Medications:</strong> Unpredictable cardiovascular effects</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏è Legal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <h4>üá∫üá∏ United States</h4>
            <p>Schedule I controlled substance - illegal to manufacture, possess, or distribute</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¨üáß United Kingdom</h4>
            <p>Class A controlled substance - maximum penalties apply</p>
          </div>
          <div class="jurisdiction">
            <h4>üá©üá™ Germany</h4>
            <p>Controlled under BtMG (Narcotics Act) - illegal</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¶üá∫ Australia</h4>
            <p>Prohibited substance - illegal to manufacture, import, or supply</p>
          </div>
        </div>
        
        <div class="therapeutic-status">
          <h4>üè• Research Status</h4>
          <p>No accepted medical use. Strictly controlled in most countries due to high potency and potential for psychological harm. Research limited to academic settings with special licenses.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Development</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1977</span>
          <p>First synthesized by Alexander Shulgin and documented in laboratory notes</p>
        </div>
        <div class="history-event">
          <span class="year">1991</span>
          <p>Detailed in PiHKAL (#26) with full synthesis and effects profile</p>
        </div>
        <div class="history-event">
          <span class="year">1990s</span>
          <p>Limited circulation in research chemical communities</p>
        </div>
        <div class="history-event">
          <span class="year">2000s</span>
          <p>Increased availability through underground chemists and internet vendors</p>
        </div>
        <div class="history-event">
          <span class="year">2012</span>
          <p>Emergency scheduled as Schedule I in the United States</p>
        </div>
        <div class="history-event">
          <span class="year">2010s</span>
          <p>Global scheduling and increased legal restrictions</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Psychonaut Culture</h4>
        <p>2C-E gained a reputation as one of the most challenging psychedelics in Shulgin's 2C series, earning nicknames like "the difficult one" due to its intense body load and demanding nature. Popular among experienced psychonauts seeking deep, transformative experiences despite the physical discomfort.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research & Studies</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Limited Academic Research</h4>
          <p>Very limited formal research due to Schedule I status. Most data comes from underground use reports and basic pharmacological studies.</p>
        </div>
        
        <div class="research-item">
          <h4>Receptor Binding Studies</h4>
          <p>Research has established high 5-HT2A receptor affinity and selectivity, explaining both therapeutic potential and intense effects.</p>
        </div>
        
        <div class="research-item">
          <h4>Safety Concerns</h4>
          <p>Case reports of adverse effects including severe vasoconstriction, hyperthermia, and psychological complications in vulnerable individuals.</p>
        </div>
        
        <div class="research-item">
          <h4>Substitution Studies</h4>
          <p>Research into structural modifications to reduce body load while maintaining therapeutic psychedelic effects.</p>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Additional Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Harm Reduction</h4>
        <ul>
          <li><a href="https://www.erowid.org/">Erowid</a> - Experience reports and detailed information</li>
          <li><a href="https://psychonautwiki.org/">PsychonautWiki</a> - Comprehensive pharmacological data</li>
          <li><a href="https://www.drugsdata.org/">DrugsData.org</a> - Substance testing and identification</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Educational Resources</h4>
        <ul>
          <li><a href="https://www.bluelight.org/">Bluelight</a> - Harm reduction community</li>
          <li><a href="https://rollsafe.org/">RollSafe.org</a> - Safer use guidelines</li>
          <li><a href="https://www.maps.org/">MAPS</a> - Psychedelic research and education</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Crisis Support</h4>
        <ul>
          <li><a href="https://www.samhsa.gov/">SAMHSA</a> - Mental health crisis support</li>
          <li><a href="https://firestone.org/">Firestone</a> - Psychedelic crisis support</li>
          <li><a href="https://www.zendoproject.org/">Zendo Project</a> - Psychedelic peer support</li>
        </ul>
      </div>
    </div>
  </div>

</div>